Antares Vision Group has announced a strategic partnership with LedgerDomain, a specialist in secure digital identity and credentialing for the healthcare supply chain.
Er-Kim has announced that they have been appointed by Immunocore as the distribution and commercialisation partner for KIMMTRAK Turkey and across the Middle East, North Africa, Caucasus and the Commonwealth of Independent States (CIS) regions.
ProFound Therapeutics has announced a four-year collaboration with Novartis to discover and develop novel therapeutics for cardiovascular disease leveraging its ProFoundry Platform.
Enhanced Genomics, a biotechnology company, has announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.
Shilpa Biocare, a fully-owned subsidiary of Shilpa Medicare, announces ahead of BIO Boston that it has secured a Europe-wide commercial supply agreement with Orion Corporation for Recombinant Human Albumin.
XL-protein has announced that it has entered into a worldwide License, Development and Commercialisation Agreement with Grifols for a long-acting biopharmaceutical product.
Medicines Discovery Catapult (MDC) and the Francis Crick Institute have announced a new strategic partnership to support the delivery of KQ Labs, a national accelerator for data-driven health science start-ups.
Clinigen, the global specialty pharmaceutical services group, has highlighted a key collaborative milestone with Shionogi, an impact-driven pharmaceutical company, marking the launch of their new strategic relationship.
